Showing results (961-970 of 1,176) with videos related to
Sort By:
Pageof 118
Cancer Cytopathology|July 18, 2013
Using the ASC:SIL ratio, human papillomavirus, and interobserver variability to assess and monitor cytopathology fellow training performanceIvan Chebib, Rema A Rao, David C Wilbur, et al.Cancer Cytopathology|February 1, 2013
Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma?William C FaquinCancer Cytopathology|January 5, 2013
The marriage of cytology and cytogeneticsPaola Dal Cin, Xiaohua Qian, Edmund S CibasCancer Cytopathology|December 11, 2012
The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou resultsMing Guo, Yun Gong, Jianping Wang, et al.Cancer Cytopathology|December 11, 2012
Analysis of tumor markers in cytological fluid obtained from computed tomography-guided needle aspiration biopsies for the diagnosis of ground-glass opacity pulmonary lesionsGa Ram Kim, Jin Hur, Hye-Jeong Lee, et al.Cancer Cytopathology|December 11, 2012
The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed casesChristopher C Griffith, Edward B Stelow, Anjali Saqi, et al.Cancer Cytopathology|February 15, 2013
Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYCEllen C Obermann, Spasenija Savic Prince, Audrey Barascud, et al.Cancer Cytopathology|February 8, 2013
To what extent does nonanalytic reasoning contribute to visual learning in cytopathology?Andrew Evered, Darren Walker, Andrew A Watt, et al.Cancer Cytopathology|June 15, 2013
High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesionDiama B Vale, Maria C Westin, Luiz C ZeferinoCancer Cytopathology|June 20, 2013
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patientsUmberto Malapelle, Claudio Bellevicine, Caterina De Luca, et al.Pageof 118